Research interests
Interstitial lung disease, sarcoidosis, LAM, alpha-1 antitrypsin deficiency[2]
Lori Shah is an Assistant Professor of Medicine (in Pediatrics) at Columbia, a transplant pulmonologist in the Lung Transplant Program and Medical Director of the NewYork-Presbyterian/Columbia Pulmonary Function Laboratory, where first-year fellows do their physiology block. She trained at SUNY Downstate (after a BA at Brooklyn College), did residency at St. Luke's-Roosevelt and PCCM fellowship at NewYork-Presbyterian/Columbia, and received the fellowship's Teacher of the Year Award in 2006. Her clinical practice covers lung transplant evaluation and the full range of advanced lung disease (ILD, COPD/emphysema, alpha-1, CF, sarcoidosis, LAM, occupational disease and pulmonary hypertension). She was first author of a 2004 Cancer paper on syndecan-1 and EGFR expression as survival markers in non-small cell lung cancer and of a Seminars review of lung transplantation in sarcoidosis, and has been a long-standing co-author on the Columbia transplant program's outcomes work, including the AJRCCM obesity/underweight mortality study, the multicenter frailty study, the Science Immunology tissue-resident memory T cell paper and the program's COVID-19 case series.
Each topic is linked to its supporting source in Sources.
Training includes NewYork-Presbyterian Hospital/Columbia University Medical Center, BA, Medical Director, Pulmonary Function Laboratory; transplant pulmonologist, and Brooklyn College, plus 4 more records.
Explore education and trainingInterstitial lung disease, sarcoidosis, LAM, alpha-1 antitrypsin deficiency[2]
Lung transplantation and advanced lung disease[2]
Pulmonary function testing[2]